Medical Xpress |
New class of type 2 diabetes drug associated with rare, life-threatening outcome
Medical Xpress A new class of drugs, known as SGLT2 inhibitors, is increasingly being prescribed for the treatment of type 2 diabetes, but may increase the risk of rare but serious complication known as diabetic ketoacidosis. In a new study published in the New ... SGLT2 Inhibitors Double the Risk for Diabetic Ketoacidosis New Diabetes Drugs May Bring On Ketoacidosis Study Confirms Link Between Diabetes Med and Rare But Dangerous Complication |
Social Plugin